Calanus

Calanus AS is a Norwegian biomarine company founded on competence on ecologically sustainable harvesting of the zooplankton species, Calanus finmarchicus, and on scientific and technological expertise related to development, manufacture and use of health- and nutrition products. The company also develops bioactive compounds based on this abundant biological resource of the North Atlantic Ocean. The company is currently conducting a human clinical study on type-2 diabetes with its lead product, Calanus® Oil. Calanus®Oil will soon be launched in selected markets, pending regulatory clearance.